EcoDrugPlus

Neuropeptide Y Receptor Type 6-Like

Ensembl ID : ENSPNAG00000024487
Gene Symbol: LOC108433913
3 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPNAG00000000779
Gene Symbol: NTSR1
3 Cross references
204 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSPNAG00000016350
Gene Symbol: NTSR1
3 Cross references
138 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSPNAG00000004793
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSPNAG00000017256
Gene Symbol: NTRK2
3 Cross references
209 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSPNAG00000007107
Gene Symbol: NTRK3
3 Cross references
193 Possible Orthologues:

Nicastrin

Ensembl ID : ENSPNAG00000027859
Gene Symbol: NCSTN
4 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSPNAG00000024413
Gene Symbol: NAMPT
3 Cross references
225 Possible Orthologues:

Nischarin

Ensembl ID : ENSPNAG00000029982
Gene Symbol: NISCH
3 Cross references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSPNAG00000015774
Gene Symbol: NOS2
4 Cross references
163 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSPNAG00000015647
Gene Symbol: NOS2
4 Cross references
163 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSPNAG00000030066
Gene Symbol: NOTCH1
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).